High-throughput identification of telomere-binding ligands based on the fluorescence regulation of DNA-copper

Luzhu Yang1, Yanjun Wang1, Baoxin Li1

  • 1Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education, Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province, School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710062, China.

Biosensors & Bioelectronics
|September 25, 2016
PubMed

Insights

A new label-free fluorescence strategy using DNA-copper nanoparticles enables high-throughput screening of telomeric G-quadruplex ligands. This method efficiently identifies compounds that inhibit telomerase activity, offering potential for new cancer drug discovery.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nanotechnology

Background:

  • G-quadruplex formation in human telomeric DNA inhibits telomerase, a target for cancer therapy.
  • Screening for telomeric G-quadruplex ligands is crucial for developing anticancer drugs.
  • A high-throughput method for screening telomere-binding ligands is urgently needed.

Purpose of the Study:

  • To develop a label-free, high-throughput fluorescence strategy for screening telomere-binding ligands.
  • To utilize DNA-copper nanoparticles (DNA-CuNPs) as a signal probe for ligand screening.
  • To identify potential anticancer agents targeting telomerase.

Main Methods:

  • A label-free fluorescence strategy employing DNA-CuNPs as a signal probe.
  • Monitoring fluorescence changes based on G-quadruplex formation induced by ligands.
  • Validation using Circular Dichroism (CD) and Telomere Repeat Amplification Protocol (TRAP) assays.

Main Results:

  • The DNA-CuNP strategy effectively distinguishes between G-quadruplex binders and non-binders via fluorescence.
  • Thirteen traditional Chinese medicines were screened, with selected ligands confirmed to form G-quadruplex structures.
  • Selected ligands demonstrated effective inhibition of telomerase activity in TRAP assays.

Conclusions:

  • The developed method provides a cost-effective, reliable, and high-throughput approach for identifying G-quadruplex ligands.
  • This strategy holds significant potential for discovering novel telomerase-targeted anticancer drugs.
  • The findings pave the way for efficient screening of large compound libraries.